Science journalist
Elie Dolgin, PhD, is a freelance science journalist who specializes in biomedical research and drug discovery.
Elie Dolgin is a science journalist who splits his time between rural Vermont and urban Massachusetts. He holds a bachelor's degree in biology from McGill University and a PhD in evolutionary genetics from the University of Edinburgh. A former news editor at STAT, Nature Medicine and The Scientist, Elie has also written for publications including the New York Times, Newsweek and Science magazine.
His 2021 feature article for Nature, "The tangled history of mRNA vaccines," gained significant recognition and was referenced widely in the scientific literature, in national newspaper stories and by award selection committees.
In The Media
Recent Projects
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.
Ultrasound enables minimally invasive 3D-printing of tissues, therapies, and more.
3D structure of the tongue’s sweet-sensing protein could guide future food designs.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with fewer side effects.
A new tool predicts where proteins fit, opening new frontiers in drug discovery.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.